Wilmington, Delaware, United States, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. – In 2021, the global peptide therapeutics market size stood at around US$ 39.34 Bn. The report for peptide therapeutics market anticipates the market to expand at 8.8% CAGR during the forecast period, from 2022 to 2031. It is projected that by 2031, the global peptide therapeutics market will cross valuation of US$ 91.25 Bn. Chronic illnesses are becoming more common and occurring more frequently as a result of a poor diet and reduced physical activity. In the forthcoming years, it is anticipated that the high prevalence as well as incidence of metabolic diseases will propel the global peptide therapeutics market.
As the number of elderly people grows, so do the incidence and also prevalence rates of various chronic problems including cardiovascular problems, diabetes, Alzheimer's, and immunological disorders. In the coming years, this aspect is anticipated to drive the global peptide demand for use in Alzheimer's peptide therapeutics. As a result of increasing demand for peptide therapeutics, market players are funding more on R&D efforts to develop novel peptide therapeutics.
Get Exclusive PDF Sample Copy of Peptide Therapeutics Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=418
The global market for peptide therapeutics is anticipated to be dominated by North America during the forecast timeframe. The regional peptide therapeutics market is growing due to strong healthcare system, advantageous reimbursement regulations, and availability of peptide therapeutics medications.
Key Findings of Market Report
- Based on application, in 2021, the cancer category led the global market for peptide therapeutics. Worldwide, cancer is the biggest leading cause of mortality. The WHO estimates that cancer will be responsible for about 10 million deaths worldwide in 2020. The capacity to deliver drugs with particular binding sites has made the use of therapeutic peptides in the treatment of cancer a viable route for the future expansion of the global market.
- The parenteral category led the global market for peptide therapies in 2021 when it came to route of administration. As it guarantees rapid kickoff time, quicker and greater bioavailability, and improved treatment outcomes, parenteral administration is the most popular mode of administration.
- In terms of technology, in 2021, the liquid phase category accounted for a major peptide therapeutics market share. For peptides with a length of under 15 amino acids, liquid phase synthesis is often preferred. Economical manufacture of peptides is made possible owing to liquid phase peptide synthesis.
Ask for References – https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=418
Global Peptide Therapeutics Market: Growth Drivers
- In light of the increase in the usage of immunopeptides in medications for cancer and tumors treatment, the immunopeptide category is predicted to develop rapidly. The immunopeptides category is projected to be driven by the soaring cases of newly diagnosed cancer patients and high prevalence of cancer.
- According to API peptide type, in 2021, the category of in-house category held a substantial portion of the global market. However, due to challenges in production due to strict quality requirements established by regulatory agencies, API producers opt for contracting out peptide manufacturing to CMOs in the biosimilar market.
Global Peptide Therapeutics Market: Key Competitors
- Teva Pharmaceutical Industries Ltd
- Eli Lilly and Company
- Takeda Pharmaceutical Company Limited
- F. Hoffmann-La Roche Ltd
- Bachem Holding AG
- Pfizer, Inc.
Make an Enquiry Before Buying – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=418
Global Peptide Therapeutics Market: Segmentation
Application
- Cancer
- Metabolic
- CVD
- Respiratory
- GIT
- Anti-infective
- Dermatology
- CNS
- Renal
Route of Administration
- Parenteral
- Oral
Type
- Innovative
- Generic
Technology
- Liquid Phase
- Solid Phase
- Hybrid Phase
Type of Molecule
- Vasopressin
- Somatostatin
- Calcitonin
- Natriuretic
- Immunopeptide
API Peptide Type
- In-house
- CMO
Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:
Ophthalmic Drugs Market: The ophthalmic drugs market is expected to reach US$ 50.2 Bn by the end of 2031 at a CAGR of 6.83% from 2022 to 2031.
Homeopathic Products Market: The global homeopathic products market is anticipated to reach more than US$ 32.4 Bn by the end of 2031 at a CAGR of 11.6% from 2022 to 2031.
Pain Management Therapeutics Market: The global pain management therapeutics market is anticipated to reach more than US$ 98.0 Bn by the end of 2031 at a CAGR of 2.9% from 2022 to 2031.
Collagen Peptide & Gelatin Market: The global collagen peptide and gelatin market is anticipated to reach more than US$ 7.8 Bn by the end of 2031 at a CAGR of 5.0% from 2022 to 2031.
Premenstrual Syndrome Treatment Market: The global premenstrual syndrome treatment market is anticipated to reach more than US$ 1.9 Bn by the end of 2031 at a CAGR of 3.4% from 2022 to 2031.
Synthetic Biology Market: The global synthetic biology market is anticipated to reach more than US$ 74.7 Bn by the end of 2031 at a CAGR of 21.3% from 2022 to 2031.
Anticoagulant Reversal Drugs Market: The global anticoagulant reversal drugs market is anticipated to reach more than US$ 2.3 Bn by the end of 2031 at a CAGR of 11.3% from 2022 to 2031.
Neuropathic Pain Therapeutics Market: Neuropathic pain therapeutics market is expected to grow at a moderate CAGR of ~5% from 2020 to 2030.
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyse information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
